Immunological Status of Patients Subjected to Cardiac Surgery: Effect of Lactoferrin on Proliferation and Production of Interleukin 6 and Tumor Necrosis Factor α by Peripheral Blood Mononuclear Cells in Vitro

Archivum Immunologiae et Therapiae Experimentalis

Volumn 45, Issue 2-3, 1997, Pages 201-212

  Właszczyk, Andrzej ^a   Zimecki, Michał ^b   Adamik, Barbara ^a   Durek, Grazyna ^a   Kübler, Andrzej ^a  

^a WROCLAW MEDICAL UNIVERSITY   (Poland)

^b INSTITUTE OF IMMUNOLOGY AND EXPERIMENTAL THERAPY   (Poland)

Author keywords

Cardiac surgery; Interleukin 6; Lactoferrin; Peripheral blood leukocytes; Proliferation; Tumor necrosis factor

Indexed keywords

INTERLEUKIN 6; LACTOFERRIN; LIPOPOLYSACCHARIDE; PHYTOHEMAGGLUTININ; TUMOR NECROSIS FACTOR ALPHA;

ADULT; ARTICLE; BIOSYNTHESIS; CELL CULTURE; CELL DIVISION; DRUG EFFECT; FEMALE; GENE EXPRESSION REGULATION; GENETICS; HEART DISEASE; HUMAN; IMMUNOLOGY; MALE; METABOLISM; MIDDLE AGED; MONONUCLEAR CELL; POSTOPERATIVE PERIOD;

ADULT; CELL DIVISION; CELLS, CULTURED; FEMALE; GENE EXPRESSION REGULATION; HEART DISEASES; HUMANS; INTERLEUKIN-6; LACTOFERRIN; LEUKOCYTES, MONONUCLEAR; LIPOPOLYSACCHARIDES; MALE; MIDDLE AGED; PHYTOHEMAGGLUTININS; POSTOPERATIVE PERIOD; TUMOR NECROSIS FACTOR-ALPHA;

EID: 0031324391     PISSN: 0004069X     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (42)

1. AKATSUKA H., IMANISHI K., INADA K., YAMASHITA H., YOSHIDA M. and UCHIYAMA T. (1994): Production of tumor necrosis factor by human T cells stimulated by superantigen, toxic shock syndrome toxin-1. Clin. Exp. Immunol., 96, 422 - 426.
2. BLANCHARD D. K., DJON J. Y., KLEIN T. W., FRIEDMAN H. and STEWARD II W. E. (1988): Protective effects of tumor necrosis factor in experimental Legionella pneumophila infection in mice via activation of PMN function. J. Leukoc. Biol., 43, 429 - 435.
3. BRITIGAN B. E., SERODY I. S., HAYEK M. B., CHARNIGA L. M. and COHEN M. S. (1991): Uptake of lactoferrin by mononuclear phagocytes inhibits their ability to form hydroxyl radical and protect them from membrane autoperoxidation. J. Immunol., 147, 4271 - 4277.
4. BURET A., DUNKLEY M. L., PANG G., CLANCY R. L. and CRIPS A. W. (1994): Pulmonary immunity to Pseudomonas aeruginosa in intestinally immunized rats: role of alveolar macrophages, tumor necrosis factor alpha and interleukin 1. Infect. Immun., 62, 5335 - 5343.
5. COSTARINO A. T. JR. (1993): The systemic inflammatory response syndrome and the respiratory distress syndrome. Curr. Opin. Anaesthesiol., 6, 981 - 992.
6. CROUCH S. R., SLATER K. J. and FLETCHER J. (1992): Regulation of cytokine release from mononuclear cells by the iron-binding lactoferrin. Blood, 80, 235 - 240.
7. ESPEVIK T. and NISSEN-MEYER J. (1986): A highly sensitive cell line WEHI 164 clone 13 for measuring cytotoxic factor/tumor necrosis factor from human monocytes. J. Immunol. Methods, 95, 99 - 105.
8. FARAH B., VUILLEMENOT A., LECOMPTE T., BARA L., PASQUIER C., JEBARA V., CARPENTIER A. and FABIANI J. N. (1994): Mycocardial neutrophil sequestration and activation related to the reperfusion of human heart during coronary artery surgery. Cardiovasc. Res., 28, 1226 - 1230.
9. HANSEN M. B., NIELSEN S. E. and BERG K. (1989): Re-examination and further development of a precise and rapid dye method for measuring cell growth/cell kill. J. Immunol. Methods, 119, 203 - 210.
10. HAVEL E. A. (1989): Evidence that tumor necrosis factor has an important role in antibacterial resistance. J. Immunol., 143, 2894 - 2899.
11. HIRATO T., AKIRA S., TAGA T. and KISHIMOTO T. (1990): Biological and clinical aspects of interleukin 6. Immunol. Today, 11, 443 - 449.
12. LEVEUGLE B., MAZURIER J, LEGRAND D., MAZURIER C., MONTRENIC J. and SPICK G. (1993): Lactotransferrin binding to its platelet receptors inhibits platelet aggregation. Eur. J. Biochem., 213, 1205 - 1211.
13. LIN J.-Y., SEGUIN R., KELLER K. and CHADEE K. (1994): Tumor necrosis factor alpha augments nitric oxide-dependent macrophage cytotoxicity against Entamoeba histolytica by enhanced expression of the nitric oxide synthase gene. Infect. Immun., 62, 1534 - 1541.
14. LIN Z., SIMPSON J. and CHEERS C. (1995): Interaction of interleukin 6, tumor necrosis factor and interleukin 1 during Listeria infection. Immunology, 85, 562 - 567.
15. LÜNERDAL B. and IYER S. (1995): Lactoferrin: molecular structure and biological function. Ann. Rev. Nutr., 15, 93 - 110.
16. MACHNICKI M., ZIMECKI M. and ZAGULSKI T. (1993): Lactoferrin regulates the release of tumor necrosis factor alpha and interleukin 6 in vivo. Int. J. Exp. Pathol., 74, 433 - 421.
17. MASSON P. L., HEREMANS J. F. and SCHONNE E. (1969): Lactoferrin, an iron-binding protein in neutrophilic leukocytes. J. Exp. Med., 130, 643 - 658.
18. MATTSBY-BALZAR I., ROSEANU A., MOTAS C., ELVERFORS J., ENBGERG I. and HANSEN L. A. (1996): Lactoferrin or a fragment thereof inhibits the endotoxin-induced IL-6 response in human monocytic cells. Paediatr. Res., 40, 257 - 262.
19. MONTREUIL J., TONNELAT T. and MULLET S. (1960): Preparation at proprietes de la lactosiderophiline du lait de femme. Bioch. Biophys. Acta, 45, 413 - 421.
20. NISHIMOTO N., YOSIHZAKI K, TAGOH H., MONDEN M., KISHIMOTO S., HIRATO T. and KISHIMOTO T. (1989): Elevation of serum interleukin 6 prior to acute phase proteins on the inflammation by surgical operation. Clin. Immunol. Immunopathol., 50, 399 - 401.
21. PARKER R. I., Mc KEOWN L. P., GALLIN J. I. and GRALNICK H. R. (1992): Absence of the largest platelet-von Willebrand multimers in patient with lactoferrin deficiency and a bleeding tendency. Thromb. Heamost., 67, 320 - 325.
22. PINSKY M. R., VINCENT J. L., DEVIERE J., ALERGE M., KAHN R. J. and DUPONT E. (1993): Serum cytokine levels in human septic shock. Relation to multiple organ failure and mortality. Chest, 103, 565 - 575.
23. REMICK D. G. (1993): Lung and gut injury induced by tumor necrosis factor. Res. Immunol., 144, 326 - 331.
24. RICH I. N. (1988): The macrophage as a production site for hematopoietic regulator molecules: sensing and responding to normal and pathophysiological signals. Anticancer Res., 8, 1015 - 1040.
25. ROUMEN R. M., HENDRIKS T., VAN DER VEN JONGERKRIJG J., NIEUWENHUIJZEN G. A., SAUERWEIN R. W., VAN DER MEER J. W. and GORIS R. J. (1993): Cytokine patterns in patients after major vascular surgery, hemorrhagic shock and severe blunt trauma. Relation with subsequent adult respiratory distress syndrome and multiple organ failure. Ann. Surg., 218, 768 - 776.
26. SALO M. (1992): Effects of anaesthesia and surgery on the immune response. Acta Anaesthesiol. Scand., 36, 201 - 220.
27. STARNES H. F., JR., PEARCE M. K., TENARI A., YIM J. H., ZON J.-C. and ABRAMS J. S. (1990): Anti-IL-6 monoclonal antibodies protect against lethal Escherichia coli infection and lethal tumor necrosis factor challange in mice. J. Immunol., 145, 4185 - 4191.
28. TILG H., TREHU E., ATKINS M. B. DINARELLO C. A. and MIER J. W. (1994): Interleukin 6 (IL-6) as an anti-inflammatory cytokine: Induction of circulating IL-1-receptor antagonist and soluble tumor necrosis factor receptor p55. Blood, 83, 113 - 118.
29. TONNENSEN E., WANSCHER M., HOHNDORF K., BRENDTZEN K., HANSEN M. B., DIAMANT M H. and TOFT P. (1993): Effect of methylprednisone on cytokine response in patient undergoing lung surgery. Acta Anaesthesiol. Scand., 37, 410 - 414.
30. TRUMPLER U. P. W., STRAUB A. and ROSENMUND A. (1989): Antibacterial prophylaxis with lactoferrin in neutropenic patients. Eur. J. Clin. Microbiol. Infect. Dis., 8, 310 - 318.
31. TUCKEY J. A., PARRY B. R. and Mc CALL J. L. (1992): Methylxanties in surgery: a bright future? Aust. N.Z.J. Surg., 62, 250 - 255.
32. 2-terminal amino acid sequence of a T-cell-derived lymphokine with growth factor activity for B-cell hybridomas. Proc. Natl. Acad. Sci. USA, 83, 9679 - 9683.
33. VINK A., UYTTENHOVE C., WANTERS P. and VAN SNICK J. (1990): Accesory factors involved in murine cell activation. Distinct roles of interleukin 1 and tumor necrosis factor. Eur. J. Immunol., 20, 1 - 6.
34. WANSCHER M., TONNENSEN E., ANTONSEN S., HOHDORF K., NIELSEN L. K. and HANSEN G. L. (1993): Increase in lactoferrin and elastase alpha-1-proteinase inhibits complexes but lack of complement activation and IL-6 response following thoracic surgery. Acta Anaesthesiol. Scand., 37, 597 - 601.
35. ZAGULSKI T., LIPIŃSKA P., ZAGULSKA A., BRONIAREK S. and JARZA̧BEK Z. (1989): Lactoferrin can protect mice against a lethal dose of Escherichia coli in experimental infection in vitro. Br. J. Exp. Pathol., 70, 697 - 704.
36. ZAOULSKI T., ZAGULSKA A. and JARZA̧BEK Z. (1993): Is nitric oxide the main killing molecule in non-specific defence system generated by endogenous lactoferrin in vivo. 11 International Conferences on Iron and Iron Proteins, Israel 2 - 7 May, abstract, p. 52.
37. ZIMECKI M. and MACHNICKI M. (1994): Lactoferrin inhibits the effector phase of delyed type hypersensitivity to sheep erythrocytes and inflammatory reactions to M. bovis (BCG). Arch. Immunol. Ther. Exp., 42, 171 - 177.
38. - murine thymocytes. Immunol. Lett, 30, 119 - 124.
39. ZIMECKI M., MAZURIER J., SPIK G. and KAPP J. A. (1995): Human lactoferrin induces phenotypic and functional changes in murine splenic B cell. Immunology, 86, 122 - 127.
40. ZIMECKI M., MAZURIER J., SPIK G. and KAPP J. A. (1995): Lactoferrin diminishes expression of surface IgM and interleukin 2 receptors on WEHI 231 cells and lowers susceptibility of those cells to anti-IgM induced cell death. Pol. J. Immunol., 20, 324.
41. ZIMECKI M., MAZURIER J., SPIK G. and KAPP J. A. (1996): Lactoferrin ihibits proliferative response and cytokine production of TH1 but not TH2 cells lines. Arch. Immunol. Ther. Exp., 44, 51 - 56.
42. ZUCCALI J. R., BROXMEYER H. E., LEVY D. and MORSE C. (1989): Lactoferrin decreases monocyte-induced fibroblast production of myeloid colony-stimulating activity by suppressing monocyte release of interleukin-1. Blood, 74, 1531 - 1537.